Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
Sep 29
Love0

Ensuring Dermatologists Practice Enhanced Antibiotic Stewardship With Sarecycline Mnemonic

By Chuck Lin No Comments
INTRODUCTIONTherapeutic Challenge How can we ensure dermatologists practice enhanced antibiotic stewardship to combat antimicrobial resistance and negative consequences of microbiome dysbiosis? Solution We developed a mnemonic ENLIGHTEN to help healthcare…
Read More
Sep 29
Love0

Selection of Nemolizumab Clinical Dosage for Atopic Dermatitis

By Chuck Lin No Comments
introductionNemolizumab is a humanized monoclonal antibody directed against the interleukin (IL)-31 receptor alpha chain (IL-31RA) that blocks signaling from neuroimmune cytokine IL-31. While IL-31 was first thought to be primarily…
Read More
Sep 29
Love0

Individual Article: Brodalumab Is an Efficacious, Safe, and Cost-Effective IL-17 Receptor Blocker for the Treatment of Moderate-to-Severe Plaque Psoriasis: 2023 Update

By Chuck Lin No Comments
INTRODUCTIONPsoriasis is a significant health and economic burden. In the United States, the prevalence of psoriasis is estimated to be 7.4 million, which accounts for ~2.2% of the population, with…
Read More
Sep 29
Love0

Cidofovir in the Management of Non-Genital Warts: A Review

By Chuck Lin No Comments
INTRODUCTIONCutaneous warts are benign growths on the skin that can affect various parts of the body, most commonly the face, hands, and feet.1 Warts affect 10% of the population and…
Read More
Sep 29
Love0

Successful Treatment of Lichen Planus With Oral Upadacitinib

By Chuck Lin No Comments
INTRODUCTIONLichen planus is an auto-inflammatory skin disorder marked by intensely pruritic, violaceous papules that commonly affect the extremities of middle-aged adults.1 Though a clear pathogenic mechanism remains unknown, some of…
Read More
Sep 16
Love0

A Review of the Efficacy of Topical Statins for Treating Disseminated Superficial Actinic Porokeratosis

By Chuck Lin No Comments
INTRODUCTIONPorokeratosis is a rare group of acquired or hereditary dermatoses characterized by pruritic, linear, or annular plaques with a keratotic border.1,2 Although the pathophysiology remains unclear, the development of porokeratosis…
Read More
Sep 16
Love0

Alopecia Areata: The Clinician and Patient Voice

By Chuck Lin No Comments
INTRODUCTIONAlopecia areata (AA) was once considered a mere cosmetic condition. Now, we know that AA is a disease that profoundly impacts patients' lives.1 Alopecia areata not only causes psychosocial distress…
Read More
Sep 01
Love0

A Randomized Control Trial Comparing the Efficacy of Platelet-Rich Plasma and 5% Topical Minoxidil for the Treatment of Androgenetic Alopecia

By Chuck Lin No Comments
INTRODUCTION Androgenetic alopecia (AGA) is a hereditary, androgen-dependent, dermatological disorder characterized by miniaturization of scalp hair. It is the most common type of progressive hair loss with varying severity and…
Read More
Sep 01
Love0

INDIVIDUAL ARTICLE: Real-World Evidence on the Use of Calcipotriene and Betamethasone Dipropionate Aerosol Foam 0.005%/0.064% in the Treatment of Psoriasis: A Review of Investigator-Initiated Studies Around the Globe

By Chuck Lin No Comments
INTRODUCTION Psoriasis is a chronic inflammatory disease that affects approximately 8 million adults in the United States.1 It is characterized by sharply demarcated, erythematous plaques with overlying scales that can…
Read More
Sep 01
Love0

INDIVIDUAL ARTICLE: Real-World Evidence on the Use of Calcipotriene and Betamethasone Dipropionate Aerosol Foam 0.005%/0.064% in the Treatment of Psoriasis: A Review of Investigator-Initiated Studies Around the Globe

By Chuck Lin No Comments
INTRODUCTION Psoriasis is a chronic inflammatory disease that affects approximately 8 million adults in the United States.1 It is characterized by sharply demarcated, erythematous plaques with overlying scales that can…
Read More
Aug 31
Love0

Individual Article: Updated Review of Topical Pharmaceuticals and Complementary and Alternative Medications for the Treatment of Onychomycosis in Both General and Special Populations in the United States

By Chuck Lin No Comments
INTRODUCTIONOnychomycosis is an infection of the nail bed or nail plate by fungal organisms. These organisms are predominantly dermatophytes and less commonly yeasts, but recent research revealed an increasing prevalence…
Read More
Aug 31
Love0

INDIVIDUAL ARTICLE: Vehicles Matter

By Chuck Lin No Comments
It has been known for decades that the sequential topical use of the vitamin D3 analog calcipotriene (Cal) and the corticosteroid betamethasone dipropionate (BD) has been shown to provide greater…
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • Treatment Strategy for Refractory Dissecting Cellulitis of the Scalp Using Bimekizumab, Isotretinoin, and Oral Antibiotics February 27, 2026
  • Molecular Insights: Immune and Barrier Dysregulation in Seborrheic Dermatitis February 25, 2026
  • Impact of TNF-α and IL-17 Biologics on Cardiometabolic Outcomes in Hidradenitis Suppurativa: Retrospective Cohort Study February 25, 2026
  • Author Spotlight: David Ciocon MD February 23, 2026
  • Non-Invasive Diagnosis of Sun Damaged Skin: Actinic Keratosis Vs Squamous Cell Carcinoma February 19, 2026

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |     ADVERTISING POLICY  |    MANAGE PREFERENCES  |  YOUR PRIVACY CHOICES

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search

  • x-twitter
  • facebook
  • linkedin
  • instagram